prostate cancer
99 projects
H2020Individual fellowship2021–2023Spain
NANOCRISPR · NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS
H2020Individual fellowship2020–2022Serbia
REPANCAN · Drug repurposing in pancreatic ductal adenocarcinoma
H2020Individual fellowship2020–2022Spain
PDASwITch · Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer
H2020Individual fellowship2020–2022Spain
RegARcis · Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation
H2020Individual fellowship2020–2022Spain
SPOT · Synthesis of Pretargeted Oncology Theranostics
H2020Individual fellowship2020–2022United Kingdom
BRCAstem · Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells
H2020Individual fellowship2020–2022Portugal
ClickandTreatCancer · Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer
H2020Individual fellowship2020–2021Belgium
INFORM · Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs
H2020Individual fellowship2020–2023Italy
PICModForPCa · Personalised Image-based Computational Modelling Framework to Forecast Prostate Cancer
2 partners · 2 countries
H2020Doctoral network2019–2023Netherlands
proEVLifeCycle · The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance
10 partners · 6 countries
H2020Individual fellowship2019–2021Italy
POLAR STAR · Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer
H2020Individual fellowship2019–2021Spain
PDX-PC · Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer
2 partners · 2 countries
H2020Individual fellowship2019–2021United Kingdom
PanILC · Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia
H2020Individual fellowship2019–2021Spain
AR-DDR · Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer
H2020Individual fellowship2019–2023Spain
COLOVOC · Reliable and specific urinary biomarkers for colorectal cancer
2 partners · 2 countries
H2020Individual fellowship2018–2020Switzerland
PCAPIP · Towards understanding non-canonical phosphatidylinositol kinases in the maintenance of prostate metabolism.
H2020Individual fellowship2018–2020Germany
PCaProTreat · Multi-omics molecular treatment targets for Prostate Cancer
H2020Individual fellowship2018–2020United Kingdom
META-DORM · Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions
2 partners · 2 countries
H2020Individual fellowship2017–2020Switzerland
STOPCa · The cryptic path of tumor-microenvironment interactions in prostate cancer
H2020Individual fellowship2017–2019United Kingdom
IVORIaN · RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer.
H2020Individual fellowship2017–2021Italy
ENDOCAM · TARGETING ENDOTHELIAL CELL AND CANCER AMOEBOID MOVEMENT TO OVERCOME RESISTANCE TO ANTI-VEGF AND ANTI-PROTEASE THERAPIES
2 partners · 2 countries
H2020Individual fellowship2017–2019Germany
DOC · Dark Ocean Cosmeceuticals -DOC-: The Cosmetical and Pharmaceutical Potential of Marine Dissolved Organic Matter
H2020Individual fellowship2017–2019Portugal
TRPLigDrugConj · TRPV1-targeted ligand-drug conjugates to treat prostate cancer
H2020Staff exchange2017–2022Ireland
3D NEONET · Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics
22 partners · 7 countries